Vetmab Biosciences, Inc. — Form D
Vetmab Biosciences, Inc. of SAN Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-05. The offering totals $5.0M, of which $575K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-05
- Form: D
- Accession: 0001932050-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $575K
- Remaining: $4.4M
- Investors: 5
- Date of first sale: 2023-11-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-498828
Issuer
- Name: Vetmab Biosciences, Inc.
- CIK: 0001932050
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3639 Midway Drive, SAN Diego, CA, 92110
- Phone: 619-723-6476
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Richard Chin | Director | San Francisco, CA |
| Richard Chin | Executive Officer | San Francisco, CA |
| Denise Bevers | Director | Norwood, MA |
| Denise Bevers | Executive Officer | Norwood, MA |
| Hangjun Zhan | Director | San Diego, CA |
| Hangjun Marie Zhan | Director | San Diego, CA |
| Richard Marie Chin | Director | San Diego, CA |
| Richard Marie Chin | Executive Officer | San Diego, CA |
| Denise Marie Bevers | Director | San Diego, CA |
| Denise Marie Bevers | Executive Officer | San Diego, CA |
Other filings by this issuer (4)
More